July 29, 2015
Actavis Inc. on Tuesday asked a New York federal judge overseeing Endo Pharmaceuticals Inc.'s case accusing it and several other generics manufacturers of infringing its patent for painkiller Opana ER to disregard a U.S. Patent and Trademark Office decision upholding Endo's patent, arguing the administrative ruling has no bearing on the pending civil case.